vs

Side-by-side financial comparison of GERON CORP (GERN) and NIP Group Inc. (NIPG). Click either name above to swap in a different company.

GERON CORP is the larger business by last-quarter revenue ($47.2M vs $39.3M, roughly 1.2× NIP Group Inc.). NIP Group Inc. runs the higher net margin — -11.9% vs -39.0%, a 27.2% gap on every dollar of revenue.

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

GERN vs NIPG — Head-to-Head

Bigger by revenue
GERN
GERN
1.2× larger
GERN
$47.2M
$39.3M
NIPG
Higher net margin
NIPG
NIPG
27.2% more per $
NIPG
-11.9%
-39.0%
GERN

Income Statement — Q3 FY2025 vs Q2 FY2024

Metric
GERN
GERN
NIPG
NIPG
Revenue
$47.2M
$39.3M
Net Profit
$-18.4M
$-4.7M
Gross Margin
6.0%
Operating Margin
-29.4%
-13.0%
Net Margin
-39.0%
-11.9%
Revenue YoY
67.1%
Net Profit YoY
30.3%
EPS (diluted)
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
NIPG
NIPG
Q3 25
$47.2M
Q2 25
$49.0M
Q1 25
$39.6M
Q3 24
$28.3M
Q2 24
$882.0K
$39.3M
Q1 24
$304.0K
Q4 23
$23.0K
Q3 23
$164.0K
Net Profit
GERN
GERN
NIPG
NIPG
Q3 25
$-18.4M
Q2 25
$-16.4M
Q1 25
$-19.8M
Q3 24
$-26.4M
Q2 24
$-67.4M
$-4.7M
Q1 24
$-55.4M
Q4 23
Q3 23
$-44.8M
Gross Margin
GERN
GERN
NIPG
NIPG
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
6.0%
Q1 24
Q4 23
Q3 23
Operating Margin
GERN
GERN
NIPG
NIPG
Q3 25
-29.4%
Q2 25
-25.4%
Q1 25
-42.2%
Q3 24
-99.8%
Q2 24
-7860.9%
-13.0%
Q1 24
-18465.1%
Q4 23
Q3 23
-29031.7%
Net Margin
GERN
GERN
NIPG
NIPG
Q3 25
-39.0%
Q2 25
-33.4%
Q1 25
-50.1%
Q3 24
-93.5%
Q2 24
-7639.8%
-11.9%
Q1 24
-18220.4%
Q4 23
Q3 23
-27320.1%
EPS (diluted)
GERN
GERN
NIPG
NIPG
Q3 25
$-0.03
Q2 25
$-0.02
Q1 25
$-0.03
Q3 24
$-0.04
Q2 24
$-0.10
Q1 24
$-0.09
Q4 23
Q3 23
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
NIPG
NIPG
Cash + ST InvestmentsLiquidity on hand
$78.1M
$6.8M
Total DebtLower is stronger
$3.8M
Stockholders' EquityBook value
$248.7M
Total Assets
$567.4M
$305.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
NIPG
NIPG
Q3 25
$78.1M
Q2 25
$77.7M
Q1 25
$83.7M
Q3 24
$60.3M
Q2 24
$116.9M
$6.8M
Q1 24
$189.8M
Q4 23
$70.0M
Q3 23
$30.7M
Total Debt
GERN
GERN
NIPG
NIPG
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
$3.8M
Q1 24
Q4 23
Q3 23
Stockholders' Equity
GERN
GERN
NIPG
NIPG
Q3 25
$248.7M
Q2 25
$259.5M
Q1 25
$268.2M
Q3 24
$292.3M
Q2 24
$306.7M
Q1 24
$344.9M
Q4 23
$247.9M
Q3 23
$290.6M
Total Assets
GERN
GERN
NIPG
NIPG
Q3 25
$567.4M
Q2 25
$555.2M
Q1 25
$562.5M
Q3 24
$444.9M
Q2 24
$449.4M
$305.3M
Q1 24
$482.1M
Q4 23
$394.1M
Q3 23
$413.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
NIPG
NIPG
Operating Cash FlowLast quarter
$-13.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
NIPG
NIPG
Q3 25
$-13.6M
Q2 25
$-27.4M
Q1 25
$-48.0M
Q3 24
$-58.9M
Q2 24
$-53.5M
Q1 24
$-62.3M
Q4 23
$-167.7M
Q3 23
$-50.8M
Free Cash Flow
GERN
GERN
NIPG
NIPG
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
$-53.7M
Q1 24
$-62.9M
Q4 23
$-168.6M
Q3 23
$-51.0M
FCF Margin
GERN
GERN
NIPG
NIPG
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
-6086.6%
Q1 24
-20680.3%
Q4 23
-732926.1%
Q3 23
-31116.5%
Capex Intensity
GERN
GERN
NIPG
NIPG
Q3 25
Q2 25
Q1 25
Q3 24
0.0%
Q2 24
23.4%
Q1 24
202.3%
Q4 23
3608.7%
Q3 23
117.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons